Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Current Pharmaceutical Design|July 22, 2011
Gene therapy for lysosomal storage diseases: progress, challenges and future prospectsSergey S Seregin, Andrea AmalfitanoViruses|October 14, 2011
Improving adenovirus based gene transfer: strategies to accomplish immune evasionSergey S Seregin, Andrea AmalfitanoExpert Opinion on Biological Therapy|September 29, 2009
Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectorsSergey S Seregin, Andrea AmalfitanoFrontiers in Immunology|May 9, 2012
Immune recognition of gene transfer vectors: focus on adenovirus as a paradigmYasser Ali Aldhamen, Sergey S Seregin, Andrea AmalfitanoInternational Immunology|December 31, 2013
Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategyYasser A Aldhamen, Sergey S Seregin, Charles F Aylsworth, et al.Clinical and Vaccine Immunology : CVI|November 19, 2010
Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunityDaniel M Appledorn, Yasser A Aldhamen, Sarah Godbehere, et al.Human Immunology|May 4, 2013
Activation of human natural killer cells by the novel innate immune modulator recombinant Eimeria antigenCharles F Aylsworth, Yasser A Aldhamen, Sergey S Seregin, et al.International Immunology|August 4, 2014
ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responsesDavid P W Rastall, Yasser A Aldhamen, Sergey S Seregin, et al.Vaccine|December 28, 2011
Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in miceSergey S Seregin, Yasser A Aldhamen, David P W Rastall, et al.Human Gene Therapy|March 11, 2011
Use of DAF-displaying adenovirus vectors reduces induction of transgene- and vector-specific adaptive immune responses in miceSergey S Seregin, Yasser A Aldhamen, Daniel M Appledorn, et al.Pageof 10